B. Brown et al., The effect of tobacco smoke, nicotine, and cotinine on the mutagenicity of4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), MUT RES-GTE, 494(1-2), 2001, pp. 21-29
Citations number
39
Categorie Soggetti
Molecular Biology & Genetics
Journal title
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) is a rodent carcinogen
that is metabolically derived from carbonyl reduction of 4-(methyinitrosam
ino)-1-(3-pyridyl)-1-butanone (NNK). NNAL can be pyridine N-oxidized to for
m NNAL-N-oxide, or conjugated to form NNAL-glucuronide-non-genotoxic metabo
lites that can be excreted in urine. Alternatively, NNAL can be alpha -hydr
oxylated at the methyl and methylene carbons adjacent to the nitroso group
to generate electrophiles that can react with biological macromolecules, su
ch as DNA and proteins. Our laboratory has previously demonstrated that the
mutagenicity of NNK was significantly inhibited by the aqueous extract of
tobacco smoke, as well as pyridine alkaloids in cigarette smoke, such as ni
cotine, cotinine and nornicotine. Given the structural similarity between N
NK and NNAL, and the metabolic activation of both by cytochromes P450, we h
ypothesized that there may be a similar inhibition of NNAL metabolism, and
consequently, inhibition of the mutagenic activity of NNAL by tobacco smoke
and its pyridine alkaloid constituents. In the present study, we evaluated
the ability of two pyridine alkaloids (nicotine and cotinine) and aqueous
cigarette smoke condensate extract (ACTE) to inhibit the mutagenicity of NN
AL in Salmonella typhimurium strain TA 1535 in the presence of a metabolic
activation system (S9). Both pyridine alkaloids tested, as well as ACTE inh
ibited the mutagenicity of NNAL in a concentration-dependent manner. The ob
served reductions in mutagen ici ty were not the result of cell killing due
to cytotoxicity. These results demonstrate that tobacco smoke contains pyr
idine alkaloids, as well as other unidentified constituents that inhibit th
e mutagenicity of NNAL, a major metabolite of NNK. (C) 2001 Elsevier Scienc
e B.V. All rights reserved.